High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 65 (3) , 667-673
- https://doi.org/10.1016/s0003-4975(97)01424-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acidThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleedingThe Annals of Thoracic Surgery, 1994
- Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiencyCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1994
- Monitoring of anticoagulation in aprotinin-treated patients during heart operationThe Annals of Thoracic Surgery, 1994
- Celite and Kaolin Produce Differing Activated Clotting Times during Cardiopulmonary Bypass under Aprotinin TherapyThe Thoracic and Cardiovascular Surgeon, 1994
- Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 1994
- Blood Conservation Techniques and Platelet Function in Cardiac SurgeryAnesthesiology, 1991
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985